Publication: Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections.

Published in: Nat Immunol 2025 Sep; ():

Authors: Ngo C, Pierini-Malosse C, Rahmani K, Valente M, Collinet N, Bessou G, Guerry C, Fabregue M, Mathieu S, Sharkaoui S, Mazzoli S, Sansoni A, Fiore F, Laprie C, Alexopoulou L, Gaya M, Gregoire C, Broggi A, Wurbel S, Rua R, Haidar N, Milpied P, Escalière B, Vu Manh TP, Fallet M, Chasson L, Tran H, Baranek T, Le Bert M, Malissen B, Zarubica A, Dalod M, Tomasello E

Summary

Plasmacytoid dendritic cells (pDCs) are major producers of type I/III interferons. As interferons are crucial for antiviral defense, pDCs are assumed to play an essential role in this process; however, robust evidence supporting this dogma is scarce. Genetic or pharmacological manipulations that eliminate pDCs or disrupt their interferon production often affect other cells, confounding interpretation. Here, to overcome this issue, we engineered pDC-less mice that are specifically and constitutively devoid of pDCs by expressing diphtheria toxin under coordinated control of the Siglech and Pacsin1 genes, uniquely coexpressed in pDCs. pDC-less mice mounted protective immunity against systemic infection with mouse cytomegalovirus and showed higher survival and less lung immunopathology to intranasal infection with influenza virus and SARS-CoV-2. Thus, contrary to the prevailing dogma, we revealed that pDCs and their interferons are dispensable or deleterious during several viral infections. pDC-less mice will enable rigorously reassessing the roles of pDCs in health and disease.

Link to Pubmed [PMID] – 41023479

Link to DOI – 10.1038/s41590-025-02288-3